Neurvati Neurosciences

Neurvati Neurosciences is a neuroscience-focused biotechnology company headquartered in the United States. With a team of 24 employees, Neurvati is dedicated to advancing innovative technologies in the field of neurological and psychiatric disorders. Neurvati's mission is to identify, acquire, and develop high-potential technologies that address a broad spectrum of neurological and psychiatric conditions. They strive to guide these projects through all stages, from clinical trials to commercialization, with a patient-centric approach. Neurvati collaborates with strategic partners to expand its reach and actively engages with patient communities to ensure the development of treatments that effectively improve patients' lives. As a portfolio company of Blackstone Life Sciences, Neurvati benefits from world-class expertise, unwavering dedication, and substantial resources. This strategic backing allows Neurvati to optimize the development and commercialization of groundbreaking neuroscience therapeutics. For more information about Neurvati Neurosciences and their groundbreaking work, please visit their website at neurvati.com.